FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine, and concerns using heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selinc).
EFFECT: intranasal application of the preparation in the concentration of 0,15 % in dose four to six drops in each nostril every 4-5 hours for 2-3 weeks allows higher clinical effectiveness in Parkinson's disease ensured by correction of neuropsycological disorders.
3 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
USING HEPTAPEPTIDE FOR TREATING ESSENTIAL TREMOR AND METHOD OF TREATING TREMOR | 2011 |
|
RU2450821C1 |
METHOD OF TREATING PARKINSON'S DISEASE | 2008 |
|
RU2375084C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2423981C2 |
METHOD OF TREATING PARKINSON'S DISEASE | 2008 |
|
RU2386458C1 |
METHOD OF TREATING PARKINSONISM | 2008 |
|
RU2381818C2 |
METHOD FOR CURATIVE EFFECT ON PATIENT BODY IN TREATMENT OF PARKINSON'S DISEASE | 2002 |
|
RU2213565C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF HEAD AND UPPER LIMBS TREMOR | 2016 |
|
RU2642984C1 |
METHOD FOR TREATMENT OF PARKINSONЪS DISEASE | 0 |
|
SU1630836A1 |
METHOD OF TREATING CHRONIC DERMATOSES | 2018 |
|
RU2709534C1 |
DIAGNOSTIC METHOD OF POSTURAL DISORDERS IN PARKINSON'S DISEASE | 2020 |
|
RU2733037C1 |
Authors
Dates
2012-05-20—Published
2011-03-21—Filed